The effectiveness of remifentanil patient-controlled analgesia is not equivalent to that of epidural analgesia for pain relief during labor, study finds.
Remifentanil patient-controlled analgesia is not equivalent to epidural analgesia for pain, pain appreciation scores, and overall satisfaction in women who request pain relief during labor, reported researchers last week at the Society for Maternal-Fetal Medicine’s 34th annual meeting, The Pregnancy Meeting™, in New Orleans.
Remifentanil patient-controlled analgesia (RPCA) is a short-acting pain reliever, an opiate, similar to pethidine. It relieves pain rapidly but wears off quickly, which makes it suitable for administration through patient-controlled analgesia. With RPCA, the patient can give herself a dose of remifentanil intravenously every few minutes. Recent studies have suggested that RCPA was equal to epidural analgesia (EA) in terms of satisfaction with pain relief, so this study-Remifentanil patient-controlled analgesia versus epidural analgesia in labor; a randomized controlled equivalence trial-set out to compare the effectiveness.
Pain appreciation was measured hourly on a visual analog scale and expressed as area under the curve (AUC). The AUC gives a time-weighted measure of total pain appreciation. It was calculated for the duration of labor and for the time that pain relief was administered. A higher AUC for pain appreciation represents higher satisfaction with pain relief.
For the study, 709 women were allocated to RPCA and 705 to EA. They were randomly chosen from healthy pregnant women who intended to deliver vaginally at 15 different hospitals in the Netherlands. During labor, 447 women in the RPCA group and 343 women in the EA group received pain relief. Among women allocated to RPCA, 344 received nothing but RPCA; in the EA group 295 received just EA. Thirteen percent of the women switched to EA after RPCA. The AUC for total pain appreciation during labor was 26.5 in the RPCA group compared with 36.0 in the EA group.
“Recent studies suggest that remifentanil patient-controlled analgesia (RPCA) is equivalent to epidural analgesia (EA) with respect to pain appreciation (satisfaction with pain relief). The aim of our study was to compare the effectiveness of RPCA with EA regarding pain appreciation,” said Liv Freeman, MD, one of the study’s authors.
“The results of the study show that RPCA is not equivalent to EA with respect to pain appreciation, ie, satisfaction with pain relief. Pain appreciation scores in women, who requested pain relief during labor, randomized to EA, are significantly better.”
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Unveiling the complexities of preterm birth risk from nativity, ethnicity, and race
March 22nd 2024A recent study dissected the relationships between maternal nativity, ethnicity, and race in influencing preterm birth rates, shedding light on disparities and suggesting avenues for future research.
Read More
Study reveals link between opioid dosage and spontaneous preterm birth risk
February 21st 2024Recent research highlighted an association between the total dose of prescribed opioids during pregnancy and the heightened risk of spontaneous preterm birth, emphasizing the need for judicious opioid use in pain management for expectant mothers.
Read More